Aubagio ‘slows brain atrophy in RRMS patients’
Aubagio ‘slows brain atrophy in RRMS patients’
Genzyme has announced results from magnetic resonance imaging (MRI) analysis of participants in the Phase III TEMSO clinical trial showing Aubagio was able to slow the loss of brain volume (or atrophy) versus a placebo over two years in patients with relapsing-remitting multiple sclerosis (RRMS)... Read More - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 11769 Views
-
Last post by accordingnature495
-
- 0 Replies
- 1822 Views
-
Last post by NHE
-
- 0 Replies
- 1513 Views
-
Last post by NHE
-
- 4 Replies
- 1537 Views
-
Last post by NHE
-
- 0 Replies
- 1243 Views
-
Last post by NHE
-
- 0 Replies
- 1573 Views
-
Last post by NHE
-
- 0 Replies
- 2036 Views
-
Last post by frodo
-
- 0 Replies
- 2088 Views
-
Last post by NHE
-
- 0 Replies
- 1682 Views
-
Last post by NHE